Navigation Links
Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya
Date:10/7/2010

EAST HANOVER, N.J., Oct. 7 /PRNewswire/ -- Novartis Pharmaceuticals Corporation today announced the availability of patient support programs for Gilenya™ (fingolimod) 0.5 mg daily, a first-line oral treatment for relapsing forms of multiple sclerosis. Gilenya was approved by the US Food and Drug Administration (FDA) on September 21, 2010.

For people with MS and healthcare professionals seeking information about Gilenya, Novartis offers free programs to learn about educational resources, the availability of free starter product, and the details of our prescription and medical co-pay support program for eligible patients. People can visit www.Gilenya.com or call 877-408-4974 for information about:  

  • The Gilenya Support Program, which offers treatment information, educational resources, assistance scheduling medical assessments and prescription benefits investigation.
  • The option of free starter product once a prescription has been written to help ensure immediate access to treatment during the benefits investigation process.  Free samples are also being provided to physician's offices and are available through the Gilenya Support Program.
  • The Gilenya Prescription Co-Pay Support Program, which will cover a significant portion of prescription out-of-pocket costs for eligible patients with commercial health insurance.*  
  • The Gilenya Medical Co-Pay Support Program, which will reduce the out-of-pocket costs associated with Gilenya initiation for eligible patients who require certain tests before starting treatment.**
  • The Novartis Patient Assistance Program (PAP), which provides access to Gilenya at no cost for eligible patients who have no third-party coverage. This program is open to all US residents without pharmacy coverage whose income is less than 500% of the Federal Poverty Level. In 2009, the Novartis PAP provided free product valued at over $232 million to
    '/>"/>

  • SOURCE Novartis Pharmaceuticals Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
    3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
    4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
    5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
    6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
    7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
    8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
    9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
    10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
    11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... /CNW/ - The Canadian Pharmacists Association (CPhA) urges the federal ... that all Canadians have the opportunity to protect themselves ... immunization. The lack of access to HPV vaccination programs ... is needlessly putting the health of Canadians at risk. ... to pose a significant threat to the health of ...
    (Date:7/6/2015)... July 6, 2015   BioClinica®, Inc ., ... today announced that it has acquired a leading ... , Inc. (Medici).  The acquisition includes affiliates ... Medici also provides a lost-to-follow-up patient locate service ...  Together with Medici, BioClinica will offer ...
    (Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ... Slings Market in the US 2015-2019" report to ... Slings market in the US to grow at a ... This report covers the present scenario and the growth ... for the period 2015-2019. To calculate the market size, ...
    Breaking Medicine Technology:CPhA Calls for HPV Strategy for Young Men to Save Lives 2BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2
    ... England Journal of Medicine the B.E.S.T,study conducted in ... DISEASE CAN BE CONTROLLED,SUCCESSFULLY” , Prof. Fabbri: “Daily ... million 200 thousand people”.,Chiesi’s commitment to pneumological research ... to the daily dose,of cortisone necessary for the ...
    ... in AACR Cancer Journal , AUSTIN, Texas--(BUSINESS WIRE)--May ... of,data describing the dramatic clinical benefit of its ... inherited form of cancer known as,Li-Fraumeni Syndrome (LFS), ... p53 tumor suppressor gene. This is the,first reported ...
    Cached Medicine Technology:Mild Asthma, a Revolutionary Therapy from Italian Research 2Mild Asthma, a Revolutionary Therapy from Italian Research 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4
    (Date:7/7/2015)... ... 07, 2015 , ... On May 29, 2015, Health Canada announced that they ... gluten-free claims for gluten free oats and foods that contain them as ingredients. , ... (GFCP) to include gluten-free oat products in Canada,” says Frank Massong, VP of ...
    (Date:7/7/2015)... ... ... Point is holding an onsite job fair to hire 400 people for its new site ... upcoming Wednesday, July 8, and Thursday, July 9, from 9:00 a.m. – 5:00 p.m. , ... well as holding onsite interviews. Interested parties are encouraged to attend the job fair ...
    (Date:7/7/2015)... ... 07, 2015 , ... CSG Government Solutions, a ... the Department of Vermont Health Access to provide Quality Assurance (QA) and Independent ... Integrated Contact Center System project. , Vermont is implementing a strategic approach to ...
    (Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... For ... finding medical providers for personal injury victims. Throughout the company’s history the goal ... deliver the care victims need in their recovery. And while Doctors on Liens ...
    (Date:7/6/2015)... ... July 06, 2015 , ... Human ... drug discovery. iPSCs are generated from adult cells, such as blood or skin, ... in the human body. , iPSC-derived cardiomyocytes have proven valuable ...
    Breaking Medicine News(10 mins):Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4
    ... 17, 2008 A new study in the Review ... meals at restaurants. Results show that both are larger and ... typical fast food meal being smaller and having fewer calories ... , James K. Binkley of Purdue University used data from ...
    ... , WASHINGTON, Dec. 17 ... A Call for Action: Enabling Healthcare Reform Using Information ... for the Obama Administration and 111th Congress to harness IT,s ... , "President-elect Obama and U.S. ...
    ... (SDSU) and the Moores Cancer Center at the University ... forces to help explain and eliminate cancer disparities. The ... Institute (NCI) of the National Institutes of Health will ... San Diego region with the goal of reducing differences ...
    ... 2008 - Elsevier, world-leading publisher of scientific, technical, and ... that, beginning in January 2009, the internationally respected ... ) (http://www.jpsmjournal.com) will be the official journal of the ... The JPSM will continue to serve as ...
    ... Therapeutics (Prime), a,nationwide pharmacy benefit management (PBM) company, ... as Chief Marketing Officer,(CMO). , ... , As ... marketing,strategy, product development and other market-related initiatives. He ...
    ... Frank, a medical doctor and,researcher at the University of ... remedy sickness and save lives should have access to the,best ... located near,research institutions in wealthy countries. , ... Frank,s idea led her to ...
    Cached Medicine News:Health News:HIMSS Releases Health IT Blueprint for Obama Administration and Congress 2Health News:HIMSS Releases Health IT Blueprint for Obama Administration and Congress 3Health News:HIMSS Releases Health IT Blueprint for Obama Administration and Congress 4Health News:$15 million grant awarded to reduce cancer disparities 2Health News:$15 million grant awarded to reduce cancer disparities 3Health News:$15 million grant awarded to reduce cancer disparities 4Health News:Elsevier announces new partnership between the Journal of Pain and Symptom Management and the AAHPM 2Health News:Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer 2Health News:Vivisimo Search Delivers Medical Knowledge to Global Health-Care Community 2
    Inquire...
    The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
    The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
    Inquire...
    Medicine Products: